Article
Epigenetics and immunotherapy in colorectal cancer: progress and promise
10 Sept 2024
Abstract excerpt
Colorectal cancer (CRC) is a common malignant tumor with the third and second highest incidence and mortality rates among various malignant tumors. Despite significant advancements in the present therapy for CRC, the majority of CRC cases feature proficient mismatch repair/microsatellite stability and have no response to immunotherapy. Therefore, the search for new treatment options holds immense importance in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
